Opinion|Videos|May 13, 2024
Evolving Perception of Autonomous Adrenal Hypercortisolism
Ralph DeFronzo, MD, leads a discussion on the evolving perception of autonomous adrenal hypercortisolism, highlighting that its prevelance is significantly greater than previously understood.
Advertisement
Episodes in this series
Advertisement
Related to this article
Patients with obesity or overweight and T2D saw substantially greater mean weight loss and HbA1c improvement with petrelintide versus placebo.
Catch up on key FDA approvals, major trial updates, and critical clinician insights from the last 3 months.
Advertisement
Advertisement
Trending on HCPLive
1
Second-Line Therapy in Fibrillary GN: Secondary Causes and Rituximab Data
2
Why "Normal" Ferritin Can Miss Iron Deficiency, With Jacquelyn Powers, MD, MS
3
Tips on Optimizing HS Biologics, Combinations, and Surgery
4
FDA Approves Once-Monthly Subcutaneous Olanzapine for Schizophrenia
5